Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Summit Therapeutics (SMMT) Beginning Cash Balance (2022 - 2024)

Summit Therapeutics' Beginning Cash Balance history spans 3 years, with the latest figure at $75.5 million for Q4 2024.

For Q4 2024, Beginning Cash Balance changed N/A year-over-year to $75.5 million; the TTM value through Dec 2025 reached $151.0 million, changed 0.0%, while the annual FY2024 figure was $100.0 million, 305.09% up from the prior year.
Beginning Cash Balance reached $75.5 million in Q4 2024 per SMMT's latest filing, roughly flat from $75.5 million in the prior quarter.
In the past five years, Beginning Cash Balance ranged from a high of $75.5 million in Q3 2024 to a low of $24.7 million in Q1 2023.
Average Beginning Cash Balance over 3 years is $50.2 million, with a median of $50.2 million recorded in 2022.